EU Parliament medtech report details rocky reg road ahead
This article was originally published in Clinica
Executive Summary
A sense of shock pervaded the medtech industry immediately after the 15 April publication of a draft report by the European Parliament’s rapporteur of the ENVI committee, Dagmar Roth-Behrendt, on the future regulation of medical devices. Controversial points made in the report include, among other things the introduction of premarket authorisation for medical devices and the re-use of all devices.
You may also be interested in...
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.
First Danish Notified Body Named Under EU's Medical Device Regulation
The EU now has a total of 45 notified bodies under the MDR.